胆固醇检测产品和服务市场－全球产业规模、份额、趋势、机会及预测（按产品、检测方法、年龄层、应用、服务提供者、地区和竞争格局划分），2021-2031年

全球胆固醇检测产品和服务市场预计将从 2025 年的 203.8 亿美元成长到 2031 年的 339.5 亿美元，复合年增长率为 8.88%。

该市场涵盖种类繁多的诊断仪器、试剂和检测套组，以及用于检测和管理高血脂症的专业检测服务。推动这一增长的关键因素包括心血管疾病发病率的上升和全球人口老化，后者需要持续监测血脂水平。此外，人们对预防性医疗保健的日益重视也推动了各种医疗机构对早期检测能力的持续需求。

然而，市场上涨趋势受到许多挑战的限制，例如医保报销制度的波动，这可能会限制病患获得必要的检测服务。例如，英国心臟基金会的数据显示，到2025年，英国将有约760万人患有心臟和循环系统疾病。虽然这些数据凸显了需要诊断干预的疾病带来的巨大负担，但医疗保健资金体系的财政限制仍然是这些产品广泛应用的一大障碍。

市场驱动因素

全球心血管疾病盛行率的不断上升是全球胆固醇检测产品和服务市场的主要驱动力，因此迫切需要频繁且精准的血脂监测来降低死亡风险。随着全球心臟相关疾病发生率的增加，医疗保健系统优先考虑旨在早期发现高风险族群的诊断干预措施，已开发国家尤其感受到这种压力。根据美国疾病管制与预防中心 (CDC) 2024 年 10 月发布的《心臟病概况》报告，2023 年美国将有 919,032 人死于心血管疾病，凸显了建立健全的检测基础设施以有效管理患者健康的重要性。这种需求也体现在商业性绩效。雅培公司在 2024 年 10 月发布的「2024 年第三季财务业绩」中报告称，其全球核心实验室诊断收入实现了 4.5% 的有机增长，这主要得益于常规诊断检测系统的持续普及。

政府支持政策鼓励定期体检，透过积极消除预防保健的障碍和改善诊断服务的可近性，进一步推动了市场扩张。公共卫生机构正在扩大大规模筛检计画的实施范围，以管理长期心血管风险，从而确保检测量的稳定。例如，英国国家审核于2024年11月发布的报告《心血管疾病预防进展》指出，英格兰国民医疗服务体系（NHS）已设定国家目标，即透过改善高胆固醇和高血压的检测和管理，到2029年预防15万例心臟病和中风。此类国家主导不仅满足了定期进行血脂检测的临床需求，也促进了社区医疗机构采用先进的检测服务，从而为市场成长创造了有利环境。

市场挑战

医疗资金报销结构的不一致以及经济限制，对全球胆固醇检测产品和服务市场的扩张构成了重大障碍。保险覆盖范围的差异或有限迫使患者自费进行常规血脂检测，从而阻碍了预防性筛检计画的广泛参与。这种经济上的困难直接减少了诊断检测的数量，尤其是在寻求早期检测的无症状人群中，并导致试剂和检测服务的产生收入停滞不前。

医疗基础设施面临的巨大财政压力进一步加剧了这个问题，导致支付方对诊断程序的支出进行严格审查和限制。根据欧洲心臟学会估计，到2024年，心血管疾病每年将对欧盟经济造成2,820亿欧元的损失。如此巨大的经济负担迫使卫生部门优先考虑急性治疗而非预防性诊断的资金投入。因此，製造商面临严峻的市场环境，预算限制和报销上限阻碍了检测产品的采购，直接阻碍了产业的永续发展。

市场趋势

直接面向消费者 (DTC) 的检测模式的兴起，从根本上改变了患者参与模式，使个人无需就医即可订购筛检检测。这种转变赋予消费者主动管理自身心血管健康的能力，促使非传统管道的血脂检测数量不断增加。同时，诊断服务提供者正在扩展这些平台，以吸引那些注重健康且追求便利的用户。例如，根据 Quest Diagnostics 于 2025 年 1 月发布的《2024 年第四季及全年财务报告》，该公司已将其主导消费者的平台扩展至约 135 项检测，扩大了高风险脂蛋白(a)胆固醇检测等筛检的覆盖范围。这项策略不仅使检查室的收入来源多元化，也刺激了对直接购买试剂组的需求。

同时，人工智慧（AI）在预测性血脂分析中的应用正在革新风险分层，它能够识别出那些可能被漏诊的高风险患者。演算法现在可以分析电子健康记录，在心血管事件发生之前识别出可能患有遗传性血脂异常症的个体，从而将市场重心从被动检测转向数据驱动的主动监测。 2025年8月《心血管报导》杂誌发表了一篇题为「医疗系统利用人工智慧识别潜在Lp(a)水平升高的患者」的文章，重点介绍了这一进展。文章通报称，家庭心臟基金会正与七家大型医疗系统合作，利用人工智慧识别未确诊的Lp(a)水平升高患者，从而增加他们获得确诊检测的机会。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章：全球胆固醇检测产品与服务市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（检测套组、试纸等）
  • 依检测类型（总胆固醇检测、高密度脂蛋白胆固醇检测、低密度脂蛋白胆固醇检测、三酸甘油酯检测、其他）
  • 依年龄组别（老年人、成年人、儿童）
  • 依应用领域（心血管疾病、糖尿病、肥胖、高血脂症等）
  • 按服务提供者（医院/诊所、诊断检查室、门诊中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美胆固醇检测产品与服务市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲胆固醇检测产品与服务市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区胆固醇检测产品与服务市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲胆固醇检测产品和服务市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲胆固醇检测产品与服务市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

13. 全球胆固醇检测产品与服务市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Roche Diagnostics
• Abbott
• Siemens Healthineers
• Beckman Coulter
• Ortho Clinical Diagnostics
• Thermo Fisher Scientific
• Bio-Rad
• Danaher
• Sekisui Diagnostics
• NowDiagnostics

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Cholesterol Testing Products & Services Market is projected to experience significant expansion, growing from a valuation of USD 20.38 Billion in 2025 to USD 33.95 Billion by 2031, registering a CAGR of 8.88%. This market encompasses a broad array of diagnostic instruments, reagents, and test kits, alongside professional laboratory services designed for the detection and management of hyperlipidemia. The primary drivers of this growth include the escalating incidence of cardiovascular conditions and an aging global population that requires consistent monitoring of lipid profiles. Furthermore, the growing focus on preventive medicine is fostering a sustained demand for early detection capabilities across a variety of healthcare environments.

However, the market's upward trajectory is moderated by challenges such as variable reimbursement frameworks, which can limit patient access to necessary testing procedures. For instance, data from the British Heart Foundation indicated that in 2025, approximately 7.6 million individuals in the United Kingdom were living with heart and circulatory diseases. While this statistic underscores the immense burden of disease necessitating diagnostic intervention, economic constraints within healthcare funding systems continue to pose a formidable barrier to the widespread adoption of these products.

Market Driver

The escalating global prevalence of cardiovascular diseases acts as the primary catalyst for the Global Cholesterol Testing Products & Services Market, creating an urgent need for frequent and precise lipid monitoring to reduce mortality risks. As the incidence of heart-related conditions rises worldwide, healthcare systems are prioritizing diagnostic interventions to identify at-risk populations early, a burden that is particularly evident in developed nations. According to the Centers for Disease Control and Prevention's 'Heart Disease Facts' report from October 2024, 919,032 people in the United States died from cardiovascular disease in 2023, underscoring the critical need for robust testing infrastructure to manage patient health effectively. This demand is reflected in commercial performance; Abbott reported in its 'Third-Quarter 2024 Financial Results' in October 2024 that global Core Laboratory Diagnostics sales increased by 4.5% on an organic basis, driven by the sustained adoption of routine diagnostic testing systems.

Supportive government initiatives promoting routine health screenings are further driving market expansion by actively removing barriers to preventive care and improving diagnostic accessibility. Public health bodies are increasingly implementing large-scale screening programs to manage long-term cardiovascular risks, thereby securing a steady volume of testing procedures. For example, the National Audit Office's November 2024 report, 'Progress in preventing cardiovascular disease,' noted that the NHS in England has set a national ambition to prevent 150,000 heart attacks and strokes by 2029 through improved detection and management of high cholesterol and blood pressure. Such state-sponsored mandates not only validate the clinical necessity of regular lipid profiling but also incentivize the adoption of advanced testing services across community health settings, fostering a conducive environment for market growth.

Market Challenge

Inconsistent reimbursement structures and economic constraints within healthcare funding constitute significant barriers to the expansion of the Global Cholesterol Testing Products & Services Market. When insurance coverage is variable or limited, patients are often compelled to pay out-of-pocket for routine lipid profiling, which discourages widespread participation in preventive screening programs. This lack of financial accessibility directly reduces the volume of diagnostic tests administered, particularly among asymptomatic populations who might otherwise seek early detection, thereby stalling revenue generation for reagents and laboratory services.

The immense financial pressure on healthcare infrastructures further exacerbates this issue, causing payers to scrutinize and restrict spending on diagnostic procedures. According to the European Society of Cardiology, in 2024, cardiovascular disease was estimated to cost the EU economy €282 billion annually. This staggering economic burden forces health administrations to prioritize funds for acute interventions rather than preventive diagnostics. Consequently, manufacturers encounter a restrictive market environment where budgetary limitations and reimbursement caps hinder the procurement of testing products, directly impeding the industry's ability to sustain growth.

Market Trends

The rise of Direct-to-Consumer (DTC) laboratory testing services is fundamentally altering patient engagement models by enabling individuals to order screenings without physician consultation. This shift empowers consumers to proactively manage their cardiovascular health, increasing the volume of lipid panels processed outside traditional pathways, while diagnostic providers scale these platforms to capture health-conscious users seeking convenience. For example, according to Quest Diagnostics' 'Fourth Quarter and Full Year 2024 Financial Results' released in January 2025, the company expanded its consumer-initiated platform to include approximately 135 tests, broadening access to screenings such as high-risk Lipoprotein(a) cholesterol testing, a strategy that diversifies laboratory revenue while stimulating demand for direct-access reagent kits.

Simultaneously, the adoption of artificial intelligence for predictive lipid profiling is revolutionizing risk stratification by identifying high-risk patients who might otherwise remain undiagnosed. Algorithms are now capable of analyzing electronic medical records to flag individuals with probable genetic lipid disorders before cardiovascular events occur, shifting the market focus from reactive testing to proactive, data-driven surveillance. Highlighting this advancement, an August 2025 article in Cardiovascular Business titled 'Health systems use AI to target patients who may have elevated Lp(a) levels' noted that the Family Heart Foundation partnered with seven large healthcare systems to utilize artificial intelligence for identifying patients with undiagnosed high lipoprotein(a) levels, thereby driving the utilization of confirmatory diagnostic assays.

Key Market Players

• Roche Diagnostics
• Abbott
• Siemens Healthineers
• Beckman Coulter
• Ortho Clinical Diagnostics
• Thermo Fisher Scientific
• Bio-Rad
• Danaher
• Sekisui Diagnostics
• NowDiagnostics

Report Scope

In this report, the Global Cholesterol Testing Products & Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cholesterol Testing Products & Services Market, By Product

• Testing Kits
• Testing Strips
• Others

Cholesterol Testing Products & Services Market, By Test

• Total Cholesterol Tests
• High Density Lipoprotein (HDL) Cholesterol Tests
• Low Density Lipoprotein (LDL) Cholesterol Tests
• Triglyceride Tests
• Others

Cholesterol Testing Products & Services Market, By Age Group

• Geriatric
• Adult
• Pediatric

Cholesterol Testing Products & Services Market, By Application

• Cardiovascular Diseases
• Diabetes
• Obesity
• Hyperlipidemia
• Others

Cholesterol Testing Products & Services Market, By Service Providers

• Hospitals and Clinics
• Diagnostic Laboratories
• Ambulatory Care Centers
• Others

Cholesterol Testing Products & Services Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cholesterol Testing Products & Services Market.

Available Customizations:

Global Cholesterol Testing Products & Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cholesterol Testing Products & Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Testing Kits, Testing Strips, Others)
  • 5.2.2. By Test (Total Cholesterol Tests, High Density Lipoprotein (HDL) Cholesterol Tests, Low Density Lipoprotein (LDL) Cholesterol Tests, Triglyceride Tests, Others)
  • 5.2.3. By Age Group (Geriatric, Adult, Pediatric)
  • 5.2.4. By Application (Cardiovascular Diseases, Diabetes, Obesity, Hyperlipidemia, Others)
  • 5.2.5. By Service Providers (Hospitals and Clinics, Diagnostic Laboratories, Ambulatory Care Centers, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Cholesterol Testing Products & Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Test
  • 6.2.3. By Age Group
  • 6.2.4. By Application
  • 6.2.5. By Service Providers
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cholesterol Testing Products & Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Test
      • 6.3.1.2.3. By Age Group
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By Service Providers
  • 6.3.2. Canada Cholesterol Testing Products & Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Test
      • 6.3.2.2.3. By Age Group
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By Service Providers
  • 6.3.3. Mexico Cholesterol Testing Products & Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Test
      • 6.3.3.2.3. By Age Group
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By Service Providers

7. Europe Cholesterol Testing Products & Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Test
  • 7.2.3. By Age Group
  • 7.2.4. By Application
  • 7.2.5. By Service Providers
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cholesterol Testing Products & Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Test
      • 7.3.1.2.3. By Age Group
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By Service Providers
  • 7.3.2. France Cholesterol Testing Products & Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Test
      • 7.3.2.2.3. By Age Group
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By Service Providers
  • 7.3.3. United Kingdom Cholesterol Testing Products & Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Test
      • 7.3.3.2.3. By Age Group
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By Service Providers
  • 7.3.4. Italy Cholesterol Testing Products & Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Test
      • 7.3.4.2.3. By Age Group
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By Service Providers
  • 7.3.5. Spain Cholesterol Testing Products & Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Test
      • 7.3.5.2.3. By Age Group
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By Service Providers

8. Asia Pacific Cholesterol Testing Products & Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Test
  • 8.2.3. By Age Group
  • 8.2.4. By Application
  • 8.2.5. By Service Providers
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cholesterol Testing Products & Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Test
      • 8.3.1.2.3. By Age Group
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By Service Providers
  • 8.3.2. India Cholesterol Testing Products & Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Test
      • 8.3.2.2.3. By Age Group
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By Service Providers
  • 8.3.3. Japan Cholesterol Testing Products & Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Test
      • 8.3.3.2.3. By Age Group
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By Service Providers
  • 8.3.4. South Korea Cholesterol Testing Products & Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Test
      • 8.3.4.2.3. By Age Group
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By Service Providers
  • 8.3.5. Australia Cholesterol Testing Products & Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Test
      • 8.3.5.2.3. By Age Group
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By Service Providers

9. Middle East & Africa Cholesterol Testing Products & Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Test
  • 9.2.3. By Age Group
  • 9.2.4. By Application
  • 9.2.5. By Service Providers
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cholesterol Testing Products & Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Test
      • 9.3.1.2.3. By Age Group
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By Service Providers
  • 9.3.2. UAE Cholesterol Testing Products & Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Test
      • 9.3.2.2.3. By Age Group
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By Service Providers
  • 9.3.3. South Africa Cholesterol Testing Products & Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Test
      • 9.3.3.2.3. By Age Group
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By Service Providers

10. South America Cholesterol Testing Products & Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Test
  • 10.2.3. By Age Group
  • 10.2.4. By Application
  • 10.2.5. By Service Providers
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cholesterol Testing Products & Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Test
      • 10.3.1.2.3. By Age Group
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By Service Providers
  • 10.3.2. Colombia Cholesterol Testing Products & Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Test
      • 10.3.2.2.3. By Age Group
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By Service Providers
  • 10.3.3. Argentina Cholesterol Testing Products & Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Test
      • 10.3.3.2.3. By Age Group
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By Service Providers

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cholesterol Testing Products & Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Roche Diagnostics
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Abbott
• 15.3. Siemens Healthineers
• 15.4. Beckman Coulter
• 15.5. Ortho Clinical Diagnostics
• 15.6. Thermo Fisher Scientific
• 15.7. Bio-Rad
• 15.8. Danaher
• 15.9. Sekisui Diagnostics
• 15.10. NowDiagnostics

16. Strategic Recommendations

17. About Us & Disclaimer